Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 11 - 14 tags : Trial save search
Lexicon’s LX9211 Shows Significant and Consistent Benefits in the Treatment of Painful Diabetic Neuropathy in Full Results From the Phase 2 RELIEF-DPN-1 Trial Presented at the 16th Annual Pain Therapeutics Summit
Published: 2022-11-14 (Crawled : 22:00) - globenewswire.com
LXRX | $1.62 -5.26% -5.56% 3.5M
|
Health Technology
|
| O: 3.43%
H: 2.07%
C: -3.73%
lx9211 treatment trial therapeutics results benefits diabetic
Onconova Therapeutics Announces Plans for a Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer, Reports Third Quarter 2022 Financial Results, and Provides a Business Update
Published: 2022-11-14 (Crawled : 21:00) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: -4.62%
H: 9.62%
C: 0.08%
trial therapeutics financial update
INmune Bio, Inc. Receives Health Canada “No Objection Letter” to Commence Clinical Trial of XPro1595 in Mild Alzheimer’s Disease
Published: 2022-11-14 (Crawled : 14:00) - globenewswire.com
INMB | News 0 d | $10.12 -4.75% -4.99% 180K
|
Health Technology
|
| O: 5.07%
H: 1.52%
C: -5.33%
disease canada health trial alzheimer’s
Assembly Biosciences Doses First Subject in Phase 1a Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of Investigational Next Generation Core Inhibitor ABI-4334
Published: 2022-11-14 (Crawled : 13:00) - investor.assemblybio.com
ASMB | $13.32 0.76% 0.75% 14K
|
Health Technology
|
| O: 0.75%
H: 8.89%
C: 7.41%
abi-4334 trial
4D Molecular Therapeutics Announces Interim Clinical Data from On-going Phase 1/2 Clinical Trial of Intravitreal 4D-150 for Wet Age-Related Macular Degeneration (wet AMD)
Published: 2022-11-14 (Crawled : 13:00) - globenewswire.com
FDMT M | $24.77 -6.14% -6.54% 570K
|
Health Technology
|
| O: 7.91%
H: 5.56%
C: -0.07%
macular trial therapeutics molecular phase 1
SELLAS Life Sciences Announces Update on Phase 3 REGAL Clinical Trial Evaluating Lead Asset, Galinpepimut-S, in Acute Myeloid Leukemia
Published: 2022-11-14 (Crawled : 13:00) - globenewswire.com
SLS | $1.615 4.87% 4.64% 2M
|
Health Technology
|
| O: -31.65%
H: 2.89%
C: -18.01%
sciences life leukemia trial update acute myeloid leukemia
CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled
Published: 2022-11-14 (Crawled : 12:20) - prnewswire.com
CTSO | $0.883 9.01% 8.27% 110K
|
Health Technology
|
| O: 6.58%
H: 0.0%
C: -4.94%
trial milestone
Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib in Lupus Nephritis at the American College of Rheumatology Convergence 2022
Published: 2022-11-14 (Crawled : 12:20) - biospace.com/
KZR | $0.8232 0.15% 0.15% 520K
|
Health Technology
|
| O: 0.13%
H: 8.13%
C: 4.46%
sciences lupus life trial positive results
Satsuma Pharmaceuticals Announces Topline Results from SUMMIT Phase 3 Trial of STS101 for the Acute Treatment of Migraine
Published: 2022-11-14 (Crawled : 12:00) - globenewswire.com
STSA | $1.1 -0.9% -0.91% 0
|
Health Technology
|
| O: -82.05%
H: 0.0%
C: 0.0%
sts101 treatment pharmaceuticals topline trial migraine
PDS Biotech Announces 100% Clinical Response in Cervical Cancer Patients in Preliminary Data from IMMUNOCERV Phase 2 Clinical Trial
Published: 2022-11-14 (Crawled : 12:00) - globenewswire.com
PDSB | $3.2 7.02% 6.56% 990K
|
Health Technology
|
| O: 23.21%
H: 7.97%
C: 2.32%
biotech trial response cancer phase 2
Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Thyroid Eye Disease (TED)
Published: 2022-11-14 (Crawled : 12:00) - globenewswire.com
VRDN | $14.23 -0.49% -0.49% 540K
|
Health Care and Social Assistan...
|
| O: -2.49%
H: 6.5%
C: 1.6%
vrdn-001 ongoing thyroid disease eye trial positive phase 1
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.